| Dr Robert A Lillo, MD | |
|
3600 W Bethel Ave, Muncie, IN 47304-5407 | |
| (765) 284-7738 | |
| (765) 213-3713 |
| Full Name | Dr Robert A Lillo |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 37 Years |
| Location | 3600 W Bethel Ave, Muncie, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902812639 | NPI | - | NPPES |
| 000000087009 | Other | IN | ANTHEM PIN |
| 100341100 | Medicaid | IN | |
| 200018973 | Other | IN | RAILROAD MEDICARE |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Indiana Orthopedics Llc | 5698667822 | 142 |
News Archive
A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced its latest release of the company's Patient Access Intelligence solution, which streamlines the front-end registration and financial clearance process for healthcare providers. The release incorporates client input and reflects the company's strategic vision to address the entire revenue cycle of patient financial care, from registration to billing.
The type and dosage of statin drugs given to patients to treat heart disease should be proactively monitored as they can have unintended adverse effects, concludes a new study published on bmj.com.
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
YM BioSciences Inc., today announced that two posters have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting to be held from April 17-21 in Washington, DC. The first poster describes the results of the previously reported collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The poster will describe activity of 111In-NLS-nimotuzumab against breast cancer cells with high and low EGFR expression.
› Verified 3 days ago
| Entity Name | Central Indiana Orthopedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063422137 PECOS PAC ID: 5698667822 Enrollment ID: O20040325000156 |
News Archive
A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced its latest release of the company's Patient Access Intelligence solution, which streamlines the front-end registration and financial clearance process for healthcare providers. The release incorporates client input and reflects the company's strategic vision to address the entire revenue cycle of patient financial care, from registration to billing.
The type and dosage of statin drugs given to patients to treat heart disease should be proactively monitored as they can have unintended adverse effects, concludes a new study published on bmj.com.
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
YM BioSciences Inc., today announced that two posters have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting to be held from April 17-21 in Washington, DC. The first poster describes the results of the previously reported collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The poster will describe activity of 111In-NLS-nimotuzumab against breast cancer cells with high and low EGFR expression.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert A Lillo, MD Po Box 1643, Muncie, IN 47308-1643 Ph: (765) 284-7738 | Dr Robert A Lillo, MD 3600 W Bethel Ave, Muncie, IN 47304-5407 Ph: (765) 284-7738 |
News Archive
A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced its latest release of the company's Patient Access Intelligence solution, which streamlines the front-end registration and financial clearance process for healthcare providers. The release incorporates client input and reflects the company's strategic vision to address the entire revenue cycle of patient financial care, from registration to billing.
The type and dosage of statin drugs given to patients to treat heart disease should be proactively monitored as they can have unintended adverse effects, concludes a new study published on bmj.com.
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
YM BioSciences Inc., today announced that two posters have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting to be held from April 17-21 in Washington, DC. The first poster describes the results of the previously reported collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The poster will describe activity of 111In-NLS-nimotuzumab against breast cancer cells with high and low EGFR expression.
› Verified 3 days ago
Miriam Lela Ibrahim, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1107 S Tillotson Ave, Ste 1, Muncie, IN 47304 Phone: 765-213-3024 Fax: 765-282-9303 | |
Cody Hartz, MA, ATC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2000 W University Ave, Muncie, IN 47306 Phone: 765-285-4469 | |
Miss Janvi Bhadra, MPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3911 W Clara Ln, Muncie, IN 47304 Phone: 765-587-0241 Fax: 765-245-9833 | |
Boris Vitvitskiy, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2525 W University Ave, Muncie, IN 47303 Phone: 765-751-5886 Fax: 765-751-5889 |